LIMK1 and Alzheimer disease: The role of LIMK1 and cofilin in AD is complicated by context-dependent regulatory mechanisms, with observed differences in pathway activity likely influenced by factors such as disease stage, neuronal type, and local concentrations of neurotoxic proteins.